ArticleThe European respiratory journal2025

Response and remission in asthma with tezepelumab: overlapping concepts informing on type-2 inflammatory-dependent treatment effects.

Samuel Mailhot-Larouche et al.PubMed ↗Publisher ↗

No numbers read from the abstract.